Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe cases

Abstract

Patients with cardiogenic shock (CS) display systemic inflammation and a high rate of infections, suggesting important immune disturbances. To explore the immune response to CS, we prospectively measured, in 24 consecutive CS patients, differential white blood cell (WBC) counts and the cytokines IL-1β, IL-5, IL-6, IL-10, TNFα, IFNγ, MCP-1 and eotaxin (CCL11), at Day 1 (T1), day 3 (T2) and day 6-8 (T3). Secondary infections and their influence on cytokines and WBCs were determined. CS induced early (T1) neutrophilia and elevated levels of IL-6, IL-10 and MCP-1, correlating with shock severity. The eosinophil chemoattractant eotaxin was elevated at T1 and decreased thereafter, and a progressive rise of blood eosinophils was noted over time. Patients with the most severe shock had reduced lymphocytes and monocytes at T2 and T3. Sixty-two percent of patients developed an infection, which did not alter the profile of immune response, except from higher IL-6 levels at T2. Therefore, CS elicits an acute pro-inflammatory response, followed by a delayed increase in blood eosinophils, consistent with the development of a tissue repair response, as well as depletion of immune cells in the most severely affected patients, which might predispose to secondary infections.

Current Understanding of Leukocyte Phenotypic and Functional Modulation During Extracorporeal Membrane Oxygenation: A Narrative Review

“…Leukocyte dysfunction is common in critical illnesses such as acute respiratory distress syndrome (ARDS), cardiogenic shock, and sepsis ( 56 – 58 , 62 ), which are also frequent indications for ECMO support. As changes in the functional immune response cannot be sufficiently characterized by the widely researched inflammatory mediators alone, due to their short half-life and exclusive origin, cellular profiling may be beneficial.…”

Association of Lymphocyte to Monocyte Ratio and Risk of in-Hospital Mortality in Patients with Cardiogenic Shock: A Propensity Score Matching Study

“… 30–32 Cuinet et al studied 24 consecutive CS patients and found that CS induced elevated levels of IL-6, IL-10 and macrophage chemoattractant protein-1 (MCP-1) at the first day, correlating with shock severity, patients with the most severe shock had reduced lymphocytes and monocytes, showed an acute pro-inflammatory response of CS patients. 33 The IABP-SHOCK trial found that inflammatory cytokines IL-8, IL-10 and IL-7 were also significantly associated with mortality of CS patients. 34 …”

A Critical Review of Hemodynamically Guided Therapy for Cardiogenic Shock: Old Habits Die Hard

“…The impact of systemic inflammatory response syndrome (SIRS) in CS is significant. In later stages of CS, a paradoxical vasodilatory phase of CS can occur due to SIRS secondary to endogenous cytokine release [35,36]. Clinical SIRS as evidenced by fever, elevated white blood cell count, and low SVR was observed in many patients with confirmed CS complicating acute myocardial infarction in the randomized SHOCK trial and often led to a secondary clinical diagnosis of suspected sepsis.…”